Cardiol Therapeutics Inc.
Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of cannabidiol as an anti-inflammatory and anti-fibrotic therapy for treating cardiovascular diseases.
The company brings together a wealth of research and development experience, advanced manufacturing capabilities, and a Management team, Board of Directors, and Scientific Advisory Board comprising business and thought leaders with extensive industry experience and expertise in commercializing prescription medicines.
Cardiol’s lead product candidate, CardiolRx™, is a pharmaceutically produced oral cannabidiol formulation being clinically developed for cardiovascular medicine. So, investing in Cardiol Therapeutics Inc Stocks can be a smart move. And, here, you can make sure of your decision to invest in Cardidol Stocks!
Update & News
Subscribe to all the latest new and insights to the financial markets with our monthly Corporate newsletter